Result : 282

Zinner syndrome

 Zakaria Haddadi, Siham Bhallil, Siham Nasri, Imane Kamaoui, Imane Skiker. March 2025, page 58

Zosteriform skin metastases

 Youssef Almheirat, Sara Bensalem, Houda Talbi, Nassiba Zarrouki, Siham Dikhaye, Nada Zizi. March 2025, page 59

Prion diseases

Prion diseases or subacute transmissible spongiform encephalopathies (TSE) are neurodegenerative diseases. The agent responsible for the disease and its transmission is a protein with an abnormal...
 Jean-Philippe Brandel. March 2025, page 65

Chemsex: a growing and evolving practice

Chemsex, the voluntary use of psychoactive substances to facilitate, initiate, increase, intensify or prolong sexual relations and performance, often involves multiple substance use. These include...
 Jean-Victor Blanc. March 2025, page 70

Atypical bacterial pneumonias

Atypical bacterial pneumonias are caused by several pathogens including Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, Chlamydia psittaci, Coxiella burnetii, and Francisella...
 Romaric Larcher, Paul Loubet. March 2025, page 75

Pregnancy and post-partum mental disorders

 Thomas Le Nerzé, Marine Le Floch, Philippe Gillard, Katell Faure, Philippe Descamps, Philippe Duverger, Élise Riquin. March 2025, page 83

News in nephroprotection

Nephroprotection aims to preserve kidney function and slow the progression of chronic kidney disease. Recent decades have been marked by an expansion of therapeutic options, likely to reduce the...
 Florence Sens, Maurice Laville, Laure Groisne, David Ciabrini. June 2025, page 6

Should students be trained in general culture to develop a more humanistic approach to medicine?

 Alain C Masquelet, Jean-François Allilaire. June 2025, page 15

Epidemiology of chronic pelvic pain

The prevalence of chronic pelvic pain (CPP) varies widely in literature due to varying definitions of cases and to the diversity of populations studied. Estimates range from 2.1% to 30.9% among...
 Solène Gouesbet, Marina Kvaskoff. June 2025, page 20

Pelvic sensitisation

Chronic pain is not just acute pain that lasts. It is also, and sometimes only, the result of an acquired dysfunction of the nociceptive system. Clinical characteristics allow us to diagnose these...
 Amélie Levesque. June 2025, page 28

Pudendal neuralgias

Diagnosis of pudendal neuralgia (NP) is clinical, based on the neuropathic type of pain and its topography, in the territory of the terminal branches of the pudendal nerve. It does not require...
 Éric Bautrant. June 2025, page 31

Bladder pain syndrome

Bladder pain syndrome (BPS), often associated with other pelvic pain syndromes, is defined as perceived chronic pain or discomfort related to the bladder, associated with other urinary symptoms...
 Shahed Borojeni, Benoit Peyronnet. June 2025, page 36

Chronic coccygodynia

Chronic coccygodynia is defined as pain in the c occyx which has been present for more than six months and which is aggravated by sitting down and/or rising. Although the diagnosis is primarily...
 Thibault Riant, Cristina Graur. June 2025, page 45

Irritable bowel syndrome

Irritable bowel syndrome (IBS) is a common functional digestive disorder affecting 4 to 10% of the population, with a female gender predominance. Although it is a benign disease, it can sometimes...
 Jean-Marc Sabaté. June 2025, page 48

Vulvodynias

Vulvodynia is a chronic pain. The distinction between so-called "provoked" vulvodynia and "spontaneous" vulvodynia allows a diagnostic and therapeutic orientation. "Provoked" vulvodynia responds to...
 Éric Bautrant. June 2025, page 55

Pelvic-perineal muscle pain syndromes

The search for muscle pain in the lower abdominal, gluteal and perineal regions is part of the systematic clinical examination of all pelvic perineal pain. These points of muscle hypersensitivity...
 Véronique Bonniaud. June 2025, page 62

Severe dysmenorrhea and endometriosis

Severe dysmenorrhoea, or grade 3 dysmenorrhoea according to the Andersch and Millson classification, is present in the vast majority of patients suffering from endometriosis from the first...
 Éric Bautrant, Chloé Lacoste, Delphine Lhuillery. June 2025, page 68

Chronic pelvi-perineal pain: 10 key messages

 Éric Bautrant. June 2025, page 75

Sporotrichoid tufted angioma

Yousef Almheirat, Mounia Benkaraache, Houda Talbi, Nassiba Zarrouki, Siham Dikhaye, Nada Zizi. June 2025, page 78

Living with… Kawasaki disease

 Alexandre Belot, Raphaël Darbon. June 2025, page 87

Neurofibromatosis type 1: recent advances

Neurofibromatosis type 1 (NF1) has been the subject of extensive research over the past decade, conducted by both French and international research groups. This work has led to significant...
 Laura Fertitta, Pierre Wolkenstein. June 2025, page 83

From vaccination to smallpox eradication

Patrick Berche. June 2025, page 98

Emergency treatment of acute cerebral ischemia

Five complementary strategies increase disability - and dependency - free survival after acute cerebral ischemia: - stroke unit care, independent on age, severity, type of stroke, and treatment; -...
 Didier Leys, Charlotte Cordonnier. November 2025, page 6

Special features of ANCA-associated vasculitides

Necrotizing vasculitis associated to antineutrophil cytoplasmic antibodies (ANCA) are one of the subgroups of vasculitis affecting small-sized vessels. Fibrinoid necrosis of the vascular wall is...
 Loïc Guillevin. November 2025, page 27

Epidemiology and risk factors of ANCAassociated vasculitides

ANCA-associated vasculitides (AAV) are a group of small-vessel vasculitides including microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with...
 Lucas Pacoureau, Maxime Beydon, Benjamin Terrier, Yann Nguyen. November 2025, page 34

Recent developments in the treatment of ANCA-associated vasculitides

The treatment of antineutrophil cytoplasm antibody-associated (ANCA) vasculitis is based on induction therapy to achieve remission, followed by maintenance therapy to prevent relapse. Management...
 Xavier Puéchal. November 2025, page 43

Towards more targeted therapies in the treatment of ANCA-associated vasculitides

The treatment of ANCA-associated vasculitides (AAV) is based on therapeutic strategies that achieve remission and significantly reduce the risk of relapse in most cases over the medium term....
 Alexandre Karras. November 2025, page 49

ANCA-associated vasculitides: 10 key messages

 Benjamin Terrier. November 2025, page 54

Giant hepatic hydatid cyst

 Ayoub Boubekri, Aissa Ismail, Mustapha Bensghir. November 2025, page 59

Functional neurological disorders

Functional Neurological Disorders (FND) are symptoms associated with dysfunctions in brain networks, often triggered by physical and/or psychological traumatic factors in vulnerable individuals....
 Béatrice Garcin. November 2025, page 60

Living with… the burden of obesity

 David Nocca. November 2025, page 65

Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?

Psychedelics, long marginalized, are now gaining renewed interest in psychiatry for their therapeutic potential. Substances
like psilocybin, LSD, and MDMA are being studied for treating...
 Michel Sabé, Federico Seragnoli, Louise Penzenstadler, Gabriel Thorens. November 2025, page 69